Home › Encyclopedia › Survodutide: Investigational Research Compound Overview
Research / Unapproved

Survodutide: Investigational Research Compound Overview

Molecular formulaC192H289N47O61
Molecular weight4232 g/mol
Registered trials29
PubChem CID171378821

What survodutide is

Survodutide is a peptide compound with the molecular formula C192H289N47O61 (PubChem CID 171378821). It does not have an FDA-approved label, and no approved indications, dosing, or safety information have been established for it. Research into this compound is ongoing and classified as investigational.

Trial footprint

Survodutide has been registered across 29 clinical trials. Among the available examples, one Phase 3 trial is examining its effects on weight loss in women during or after menopause and has not yet begun recruiting. Two completed Phase 1 trials have looked at how different formulations of the compound are absorbed by the body and whether it affects blood levels of bupropion, caffeine, and midazolam.

FAQ

Is survodutide FDA-approved?
No, survodutide does not have an FDA-approved label. It is currently classified as an investigational compound studied in clinical trials.
What is survodutide being studied for?
Based on registered trials, survodutide is being studied in areas such as weight management in women during or after menopause. Other trials have examined how the body absorbs different formulations of the compound and its interaction with other substances like bupropion, caffeine, and midazolam.
How many clinical trials involve survodutide?
There are 29 registered clinical trials involving survodutide. These range from early-phase studies in healthy volunteers to later-phase trials in specific patient populations.
What is the chemical identity of survodutide?
Survodutide is a large peptide compound with the molecular formula C192H289N47O61. It is cataloged in PubChem under CID 171378821.
Are there known side effects of survodutide?
No adverse event report data is currently available for survodutide in the data reviewed. Because it lacks an approved label, comprehensive safety information has not been established.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-11-07